galcanezumab (Q25326707)

humanized monoclonal antibodies for migraine prevention

LY-2951742
LY2951742
clone III

Language	Label	Description	Also known as
English	galcanezumab	humanized monoclonal antibodies for migraine prevention	LY-2951742 LY2951742 clone III

Statements

instance of

type of chemical entity

0 references

0 references

0 references

Emgality.jpg
4,032 × 1,459; 809 KB

0 references

defined daily dose

4 milligram

route of administration

parenteral route of administration

1 reference

reference URL

https://www.whocc.no/atc_ddd_index/?code=N02CD02

World Health Organisation international non-proprietary name

galcanezumab (English)

0 references

LiverTox likelihood score

LiverTox toxicity likelihood category E

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Galcanezumab

last update

15 April 2019

subject has role

monoclonal antibody

0 references

Identifiers

0 references

0 references

0 references

World Health Organisation international non-proprietary name numeric ID

10277

0 references

Guide to Pharmacology Ligand ID

0 references

0 references

1 reference

6 July 2021

CAS no.: 1578199-75-3 (English)

title

Galcanezumab (English)

UNII

55KHL3P693

0 references

MedlinePlus drug identifier

a618063

0 references

Google Knowledge Graph ID

/g/11b_2tcq26

0 references

WikiProjectMed ID

Galcanezumab

0 references

galcanezumab (Q25326707)

Statements

Identifiers

Sitelinks

Wikipedia(8 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

galcanezumab (Q25326707)

Statements

Identifiers

Sitelinks

Wikipedia(8 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Search